
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7464027
[patent_doc_number] => 20040053324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents'
[patent_app_type] => new
[patent_app_number] => 10/232759
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 41211
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10232759
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/232759 | Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents | Aug 29, 2002 | Abandoned |
Array
(
[id] => 6843577
[patent_doc_number] => 20030148924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Methods and pharmaceutical compositions of healing wounds'
[patent_app_type] => new
[patent_app_number] => 10/214228
[patent_app_country] => US
[patent_app_date] => 2002-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20044
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148924.pdf
[firstpage_image] =>[orig_patent_app_number] => 10214228
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/214228 | Methods and pharmaceutical compositions of healing wounds | Aug 7, 2002 | Abandoned |
Array
(
[id] => 204348
[patent_doc_number] => 07629153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'Methods and compositions relating to improved lentiviral vector production systems'
[patent_app_type] => utility
[patent_app_number] => 10/209952
[patent_app_country] => US
[patent_app_date] => 2002-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 25059
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/629/07629153.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209952 | Methods and compositions relating to improved lentiviral vector production systems | Jul 31, 2002 | Issued |
Array
(
[id] => 6871777
[patent_doc_number] => 20030084467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints'
[patent_app_type] => new
[patent_app_number] => 10/209615
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 10456
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20030084467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209615
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209615 | Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints | Jul 29, 2002 | Abandoned |
Array
(
[id] => 439001
[patent_doc_number] => 07258854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Targeted chromosomal genomic alterations with modified single stranded oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/209787
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 47906
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/258/07258854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209787
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209787 | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides | Jul 29, 2002 | Issued |
Array
(
[id] => 6779190
[patent_doc_number] => 20030050272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Nucleic acids, polypeptides, and methods for modulating apoptosis'
[patent_app_type] => new
[patent_app_number] => 10/200148
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 22905
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050272.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200148
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200148 | Method for inducing apoptosis using apoptosis-specific EIF5-A | Jul 22, 2002 | Issued |
Array
(
[id] => 6797008
[patent_doc_number] => 20030175882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/197942
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 41231
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175882.pdf
[firstpage_image] =>[orig_patent_app_number] => 10197942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/197942 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 17, 2002 | Abandoned |
Array
(
[id] => 6721328
[patent_doc_number] => 20030055018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Modulation of phosphoinositide 3-kinase activity'
[patent_app_type] => new
[patent_app_number] => 10/193934
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11790
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193934 | Modulation of phosphoinositide 3-kinase activity | Jul 10, 2002 | Abandoned |
Array
(
[id] => 7367332
[patent_doc_number] => 20040006031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Antisense modulation of HMG-CoA reductase expression'
[patent_app_type] => new
[patent_app_number] => 10/190366
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34487
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006031.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190366
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190366 | Antisense modulation of HMG-CoA reductase expression | Jul 1, 2002 | Abandoned |
Array
(
[id] => 7460635
[patent_doc_number] => 20040197766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Methods and compositions for the treatment and diagnosis of body weight disorders'
[patent_app_type] => new
[patent_app_number] => 10/186499
[patent_app_country] => US
[patent_app_date] => 2002-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28479
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197766.pdf
[firstpage_image] =>[orig_patent_app_number] => 10186499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/186499 | Methods and compositions for the treatment and diagnosis of body weight disorders | Jun 30, 2002 | Abandoned |
Array
(
[id] => 6792519
[patent_doc_number] => 20030087863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Methods for diagnosing and treating a disease mediated by decreased MMP-2 function'
[patent_app_type] => new
[patent_app_number] => 10/185433
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27090
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10185433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/185433 | Methods for diagnosing and treating a disease mediated by decreased MMP-2 function | Jun 27, 2002 | Abandoned |
Array
(
[id] => 6765216
[patent_doc_number] => 20030099614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => '2-Methoxyestradiol-induced apoptosis in cancer cells'
[patent_app_type] => new
[patent_app_number] => 10/180893
[patent_app_country] => US
[patent_app_date] => 2002-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16380
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099614.pdf
[firstpage_image] =>[orig_patent_app_number] => 10180893
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/180893 | 2-Methoxyestradiol-induced apoptosis in cancer cells | Jun 24, 2002 | Abandoned |
Array
(
[id] => 6825204
[patent_doc_number] => 20030235826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Gene and protein specific for excitable tissues'
[patent_app_type] => new
[patent_app_number] => 10/177917
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18375
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20030235826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177917 | Gene and protein specific for excitable tissues | Jun 23, 2002 | Abandoned |
Array
(
[id] => 6653034
[patent_doc_number] => 20030008824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Stimulation of vascularization with VEGF-B'
[patent_app_type] => new
[patent_app_number] => 10/175153
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7872
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175153 | Stimulation of vascularization with VEGF-B-186 | Jun 19, 2002 | Issued |
Array
(
[id] => 6857864
[patent_doc_number] => 20030131365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Genetically engineered animals for use as organ donors'
[patent_app_type] => new
[patent_app_number] => 10/172459
[patent_app_country] => US
[patent_app_date] => 2002-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10212
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20030131365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10172459
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/172459 | Genetically engineered animals for use as organ donors | Jun 11, 2002 | Abandoned |
| 10/009198 | Pharmaceutical composition comprising no or at least a no donor compound or another compound capable of releasing or inducing no formation in cells | Jun 9, 2002 | Abandoned |
Array
(
[id] => 6861017
[patent_doc_number] => 20030092025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Tumore endothelial market 7alpha molecules and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/156487
[patent_app_country] => US
[patent_app_date] => 2002-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29958
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10156487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/156487 | Tumore endothelial market 7alpha molecules and uses thereof | May 27, 2002 | Abandoned |
Array
(
[id] => 545115
[patent_doc_number] => 07169913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'Engineered secreted alkaline phosphatase (SEAP) reporter genes and polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/155229
[patent_app_country] => US
[patent_app_date] => 2002-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9563
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10155229
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/155229 | Engineered secreted alkaline phosphatase (SEAP) reporter genes and polypeptides | May 27, 2002 | Issued |
| 09/830913 | Corticosteroid synthesis-associated genes | May 12, 2002 | Abandoned |
Array
(
[id] => 7288057
[patent_doc_number] => 20040147465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Treatment for wounds'
[patent_app_type] => new
[patent_app_number] => 10/143536
[patent_app_country] => US
[patent_app_date] => 2002-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 17072
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147465.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143536
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143536 | Treatment for wounds | May 8, 2002 | Issued |